A majority of jails in the United States rely on an opt-in (voluntary) rather than opt-out (universal) approach to testing for sexually transmitted infections (STIs). This study compares an opt-out approach at intake to opt-in testing during incarceration and estimates the prevalence of common STIs among jail inmates. Data derive from a universal intake pilot testing program (n = 298) and an established, student-led voluntary testing program (n = 1,963), respectively. The adjusted prevalence as well as the odds of testing positive for chlamydia were significantly higher in the opt-out program (p = .025 and .008, respectively) than the opt-in program but not for gonorrhea (p = .402 and .300, respectively). These results demonstrate the potential public health benefit of implementation of universal STI testing of jail inmates.
AralS. O., HolmesK. K. (1990). Epidemiology of sexual behavior and sexually transmitted diseases. In HolmesK. K., MardhP. A., SparlingP. F., WiesnerP. J., CatesW.Jr, LemonS. M., StammW. E. (Eds.), Sexually transmitted diseases (2nd ed., pp. 19–36). New York, NY: McGraw-Hill.
2.
BarryP. M., KentC. K., ScottK. C., GoldensonJ., KlausnerJ. D. (2009). Is jail screening associated with a decrease in chlamydia positivity among females seeking health services at community clinics? San Francisco, 1997-2004. Sexually Transmitted Diseases, 36, S22–S28. doi:10.1097/OLQ.0b013e31815ed7c8
3.
BeckwithC. G., ZallerN. D., FuJ. J., MontagueB. T., RichJ. D. (2010). Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. Journal of Acquired Immune Deficiency Syndromes, 55, S49–S55. doi:10.1097/QAI.0b013e3181f9c0f7
4.
BernsteinK. T., ChowJ. M., RuizJ., SchachterJ., HorowitzE., BunnellR., BolanG. (2006). Chlamydia trachomatis and Neisseria gonorrhoeae infections among men and women entering California prisons. American Journal of Public Health, 96, 1862–1866. doi:10.2105/AJPH.2004.056374
5.
BroadJ., CoxT., RodriguezS., MansourM., MennellaC., Murphy-SwallowD.…WongW. (2009). The impact of discontinuation of male STD screening services at a large urban county jail: Chicago, 2002-2004. Sexually Transmitted Diseases, 36, S49–S52. doi:10.1097/OLQ.0b013e318156159a
6.
BrownC. K., EarleyM., ShaikhR., FickenscherJ., OttJ., PersonA.…MargalitR. (2014). Voluntary STD testing and treatment program at a metropolitan correctional facility: Evaluation of test acceptability and associated risk factors. Journal of Correctional Health Care, 20, 70–80. doi:10.1177/1078345813508748; doi:10.1177/1078345813508748
7.
Centers for Disease Control and Prevention. (2013). STD trends in the United States, 2011: National data for chlamydia, gonorrhea, and syphilis. Atlanta, GA: U.S. Department of Health and Human Services.
8.
Centers for Disease Control and Prevention. (2014). Sexually transmitted disease surveillance 2012. Atlanta, GA: U.S. Department of Health and Human Services.
9.
ChandlerR. K., FletcherB. W., VolkowN. D. (2009). Treating drug abuse and addiction in the criminal justice system. Journal of the American Medical Association, 301, 183–190.
10.
ChowJ. M., JoesoefM. R., KentC., WeinstockH., FentonK. (2009). Responding to the burden of STD, HIV, and viral hepatitis in correctional populations through program collaboration and integration. Sexually Transmitted Diseases, 36, S1.
FlaniganT. P., ZallerN., BeckwithC. G., BazermanL. B., RanaA., GardnerA.…AlticeF. L. (2010). Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: Still a missed opportunity for public health and HIV prevention. Journal of Acquired Immune Deficiency Syndromes, 55, S78–S83.
13.
FranklinW. B., KatyalM., MahajanR., ParvezF. M. (2012). Chlamydia and gonorrhea screening using urine-based nucleic acid amplification testing among males entering New York City jails: A pilot study. Journal of Correctional Health Care, 18, 120–130.
14.
GlazeL. E., ParksE. (2012). Correctional populations in the United States, 2011 (NCJ 239972). Washington, DC: Bureau of Justice Statistics. Retrieved from http://www.bjs.gov/index.cfm?ty=pbdetail&iid=4537
15.
GoldensonJ., HennesseyM. (2009). Correctional health care must be recognized as an integral part of the public health sector. Sexually Transmitted Diseases, 36, S3.
16.
GopalappaC., HuangY. A., GiftT. L., Owusu-EduseiK., TaylorM., GalesV. (2013). Cost-effectiveness of screening men in Maricopa County jails for chlamydia and gonorrhea to avert infections in women. Sexually Transmitted Diseases, 40, 776–783.
KouyoumdjianF. G., LetoD., JohnS., HeneinH., BondyS. (2012). A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. International Journal of STD and AIDS, 23, 248–254.
21.
KulkarniS. P., BaldwinS., LightstoneA. S., GelbergL., DiamantA. L. (2010). Is incarceration a contributor to health disparities? Access to care of formerly incarcerated adults. Journal of Community Health, 35, 268–274.
22.
LiuT., BazermanL., PinkstonM., NunnA., RanaA., BeckwithC. G. (2013). Co-occurring HIV risk behaviors among males entering jail. arXiv Preprint arXiv:1303.6169. Retrieved from http://arxiv.org/abs/1303.6169
23.
LoweP., O’LoughlinP., EvansK., WhiteM., BartleyP. B., VohraR. (2006). Comparison of the gen-probe APTIMA combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women. Journal of Clinical Microbiology, 44, 2619–2621. doi:44/7/2619 [pii]
24.
MeyersD. S., HalvorsonH., LuckhauptS. (2007). Screening for chlamydial infection: An evidence update for the U.S. Preventive services task force. Annals of Internal Medicine, 147, 135–142.
25.
MeyersD., WolffT., GregoryK., MarionL., MoyerV., NelsonH.… USPSTF. (2008). USPSTF recommendations for STI screening. American Family Physician, 77, 819–824.
26.
Owusu-EduseiK., GiftT. L., ChessonH. W., KentC. K. (2013). Investigating the potential public health benefit of jail-based screening and treatment programs for chlamydia. American Journal of Epidemiology, 177, 463–473.
27.
PathelaP., HennessyR. R., BlankS., ParvezF., FranklinW., SchillingerJ. A. (2009). The contribution of a urine-based jail screening program to citywide male chlamydia and gonorrhea case rates in New York City. Sexually Transmitted Diseases, 36, S58–S61.
28.
SchroderK. E., CareyM. P., VanableP. A. (2003). Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Annals of Behavioral Medicine, 26, 104–123.
29.
SieckC. J., DembeA. E. (2011). Results of a pilot study of pre-release STD testing and inmates’ risk behaviors in an Ohio prison. Journal of Urban Health, 88, 690–699.
30.
StataCorpLP. (2013). Stata version 13.0. College Station, TX: Author.
31.
TabachnickB. G., FidellL. S. (2001). Using multivariate statistics. Needham Heights, MA: Allyn and Bacon.
32.
TorroneE. A., JohnsonR. E., TianL. H., PappJ. R., DattaS. D., WeinstockH. S. (2013). Prevalence of Neisseria gonorrhoeae among persons 14 to 39 years of age, United States, 1999 to 2008. Sexually Transmitted Diseases, 40, 202–205.
33.
WilliamsR. (2012). Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata Journal, 12, 308.
34.
WorkowskiK. A. (2013). In the clinic. Chlamydia and gonorrhea. Annals of Internal Medicine, 158, 504.
35.
WorkowskiK. A., BermanS. (2010). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommendations and Reports, 59, 1–110.
36.
World Health Organization. (2013). Baseline report on global sexually transmitted infection surveillance 2012. Geneva, Switzerland: Author.
